Gaudin C - Search Results

1

In situ demonstration of renal-cell-carcinoma-specific T-cell clones.

Caignard A, Guillard M, Gaudin C, Escudier B, Triebel F, Dietrich PY. Caignard A, et al. Among authors: gaudin c. Int J Cancer. 1996 May 16;66(4):564-70. doi: 10.1002/(SICI)1097-0215(19960516)66:4<564::AID-IJC23>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8635875

2

In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.

Gaudin C, Dietrich PY, Robache S, Guillard M, Escudier B, Lacombe MJ, Kumar A, Triebel F, Caignard A. Gaudin C, et al. Cancer Res. 1995 Feb 1;55(3):685-90. Cancer Res. 1995. PMID: 7834641

3

T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions.

Farace F, Orlanducci F, Dietrich PY, Gaudin C, Angevin E, Courtier MH, Bayle C, Hercend T, Triebel F. Farace F, et al. Among authors: gaudin c. J Immunol. 1994 Nov 1;153(9):4281-90. J Immunol. 1994. PMID: 7930628

4

Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors.

Kumar A, Farace F, Gaudin C, Triebel F. Kumar A, et al. Among authors: gaudin c. J Clin Invest. 1996 Mar 1;97(5):1219-26. doi: 10.1172/JCI118536. J Clin Invest. 1996. PMID: 8636433 Free PMC article. Clinical Trial.

5

Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.

Angevin E, Kremer F, Gaudin C, Hercend T, Triebel F. Angevin E, et al. Among authors: gaudin c. Int J Cancer. 1997 Jul 29;72(3):431-40. doi: 10.1002/(sici)1097-0215(19970729)72:3<431::aid-ijc10>3.0.co;2-f. Int J Cancer. 1997. PMID: 9247286

6

A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.

Gaudin C, Kremer F, Angevin E, Scott V, Triebel F. Gaudin C, et al. J Immunol. 1999 Feb 1;162(3):1730-8. J Immunol. 1999. PMID: 9973436

7

A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ.

Ronsin C, Chung-Scott V, Poullion I, Aknouche N, Gaudin C, Triebel F. Ronsin C, et al. Among authors: gaudin c. J Immunol. 1999 Jul 1;163(1):483-90. J Immunol. 1999. PMID: 10384152

8

Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction.

Guerra N, Michel F, Gati A, Gaudin C, Mishal Z, Escudier B, Acuto O, Chouaib S, Caignard A. Guerra N, et al. Among authors: gaudin c. Blood. 2002 Oct 15;100(8):2874-81. doi: 10.1182/blood-2002-02-0643. Blood. 2002. PMID: 12351398 Free article.

9

CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.

Gati A, Guerra N, Gaudin C, Da Rocha S, Escudier B, Lécluse Y, Bettaieb A, Chouaib S, Caignard A. Gati A, et al. Among authors: gaudin c. Cancer Res. 2003 Nov 1;63(21):7475-82. Cancer Res. 2003. PMID: 14612548

10

[Repertory of T lymphocytes in patients with stage A chronic lymphoid leukemia: revealed by monoclonal expansion of T cells in vivo].

Farace F, Kremer F, Dietrich PY, Gaudin C, Angevin E, Courtier MH, Bayle C, Hercend T, Triebel F. Farace F, et al. Among authors: gaudin c. Bull Cancer. 1994 Oct;81(10):897-9. Bull Cancer. 1994. PMID: 7734775 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters